About Endovascular Engineering
Endovascular Engineering is a company based in Menlo Park (United States) founded in 2019.. Endovascular Engineering has raised $42 million across 3 funding rounds from investors including HHS, Cordis and 415 Capital. Endovascular Engineering offers products and services including Hēlo Thrombectomy System. Endovascular Engineering operates in a competitive market with competitors including Inari Medical, Akura Medical, Magneto Thrombectomy, EmerStat and Retriever Medical, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$42 M (USD)
in 3 rounds
-
Latest Funding Round
$42 M (USD), Series B
Feb 18, 2025
-
Investors
HHS
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endovascular Engineering
Endovascular Engineering offers a comprehensive portfolio of products and services, including Hēlo Thrombectomy System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for breaking down and removing blood clots via agitation and aspiration.
Unlock access to complete
Funding Insights of Endovascular Engineering
Endovascular Engineering has successfully raised a total of $42M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $42 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $42.0M
-
First Round
First Round
(20 Sep 2021)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series B - Endovascular Engineering | Valuation | 415 CAPITAL , S3 Ventures | |
| Apr, 2022 | Amount | Seed - Endovascular Engineering | Valuation | Cordis , Sante |
|
| Sep, 2021 | Amount | Grant - Endovascular Engineering | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Endovascular Engineering
Endovascular Engineering has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Cordis and 415 Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in medical technology innovations.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided to Texas-based startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Endovascular Engineering
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Endovascular Engineering
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endovascular Engineering Comparisons
Competitors of Endovascular Engineering
Endovascular Engineering operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inari Medical, Akura Medical, Magneto Thrombectomy, EmerStat and Retriever Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Catheter-based thrombectomy devices for vascular emboli removal are developed.
|
|
| domain | founded_year | HQ Location |
Catheter-based thrombectomy devices for thrombus removal are developed.
|
|
| domain | founded_year | HQ Location |
Thrombectomy solutions are developed for blood clot removal in arteries.
|
|
| domain | founded_year | HQ Location |
Creates innovative hemostatic devices for efficient trauma care and surgical applications.
|
|
| domain | founded_year | HQ Location |
Provides medical devices for vascular care and clot removal treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Endovascular Engineering
Frequently Asked Questions about Endovascular Engineering
When was Endovascular Engineering founded?
Endovascular Engineering was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is Endovascular Engineering located?
Endovascular Engineering is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Endovascular Engineering a funded company?
Endovascular Engineering is a funded company, having raised a total of $42M across 3 funding rounds to date. The company's 1st funding round was a Grant of $298.2K, raised on Sep 20, 2021.
What does Endovascular Engineering do?
Endovascular Engineering was established in 2019 in Menlo Park, United States. Services in engineering are offered to companies involved in medical device manufacturing. Focus is placed on supporting product development and production processes within the medical technology sector. Operations are conducted from the United States, with resources accessible via the domain endovascularengineering.com. Expertise is directed toward endovascular applications in device engineering.
Who are the top competitors of Endovascular Engineering?
Endovascular Engineering's top competitors include Inari Medical, Akura Medical and Magneto Thrombectomy.
What products or services does Endovascular Engineering offer?
Endovascular Engineering offers Hēlo Thrombectomy System.
Who are Endovascular Engineering's investors?
Endovascular Engineering has 7 investors. Key investors include HHS, Cordis, 415 Capital, Panakes Partners, and S3 Ventures.